Nexalin Technology, Inc. (NXLIW) は上場企業です ヘルスケア セクターの Medical - Devices 業界で事業展開. 本社所在地は Houston, TX, アメリカ. 現CEOは Mark White.
NXLIW を有する IPO日 2022-09-16, 6 名の正社員, に上場 NASDAQ Capital Marke, 時価総額 $283.87K.
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. It also engages in the development of Generation 2, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiates, chronic pain, Alzheimer's disease, and dementia. The company was incorporated in 2021 and is headquartered in Houston, Texas.
